Tag: Progression-Free Survival

A new study finds that an elevated platelet-to-lymphocyte ratio from a routine blood count strongly predicts poorer survival in relapsed ...

A new study shows that combining baseline dual-layer spectral detector CT measurements with clinical factors such as B symptoms and ...

A meta-analysis of 17 studies finds that Helicobacter pylori infection is associated with worse overall and progression-free survival in cancer ...

A new study shows that a simple index combining hemoglobin and the albumin-to-alkaline phosphatase ratio can predict survival outcomes in ...

A German phase II trial called TRITICC-2 is testing whether oral trifluridine/tipiracil combined with nanoliposomal irinotecan can improve outcomes for ...

A post hoc analysis of the CheckMate 9ER trial links early worsening of bone pain and sleep quality to higher ...

The final results of the German CARO study show that carfilzomib-based regimens achieve high adherence, trial-consistent effectiveness, and stable quality ...

A pooled analysis of four clinical trials finds that liver metastases are a strong negative prognostic factor for chemotherapy-treated pancreatic ...

A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...

A matching-adjusted indirect comparison of two landmark trials suggests retifanlimab significantly prolongs progression-free survival compared with avelumab in metastatic Merkel ...